Gene Therapy in Treating Patients With Stage III or Stage IV Melanoma

Clinical trial NCT00003646 · COMPLETED

Trial details

NCT number: NCT00003646
Sponsor: Vical
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Stage IV Melanoma Stage III Melanoma Recurrent Melanoma

Start date: 1998-08-01
Primary completion: 2002-03-01
Enrollment: 78

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.